CDSCO and ADR reporting in India

Pharm D Intern at viswabharathi superspeciality hospital um viswabharathi superspeciality hospital
19. Aug 2016
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
CDSCO and ADR reporting in India
1 von 16

Más contenido relacionado

Was ist angesagt?

Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisationbdvfgbdhg
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )
Indian regulatory requirements- CDSCO ( IP-2 / UNIT 5 )JAYACHANDRA AKUTHOTA
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.Audumbar Mali
CENTRAL DRUG STANDARD CONTROL ORGANISATION  (CDSCO)CENTRAL DRUG STANDARD CONTROL ORGANISATION  (CDSCO)
CENTRAL DRUG STANDARD CONTROL ORGANISATION (CDSCO)Vijay Banwala
CIOMS (1).pptxCIOMS (1).pptx
CIOMS (1).pptxSanjay522244
Abbreviated New Drug Application [ANDA]Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Sagar Savale

Destacado

Summary Of Schedule YSummary Of Schedule Y
Summary Of Schedule Ylekshmilnair
Schedule ySchedule y
Schedule yMalla Reddy College of Pharmacy
EmeaEmea
EmeaRanjeet Singh
Schedule YSchedule Y
Schedule YFardan Qadeer
Schedule ySchedule y
Schedule ypharmacologyseminars
Schedule y, mk sharmaSchedule y, mk sharma
Schedule y, mk sharmaSHARDA UNIVERSITY

Similar a CDSCO and ADR reporting in India

Cdsco Roles and ResponsibilitiesCdsco Roles and Responsibilities
Cdsco Roles and ResponsibilitiesSandip Mavchi
Regulatory aspectsRegulatory aspects
Regulatory aspectsSampath Kumar
Nutraceuticals ppt (1)Nutraceuticals ppt (1)
Nutraceuticals ppt (1)sai sree
Pharmacovigilance Programs of India PvPiPharmacovigilance Programs of India PvPi
Pharmacovigilance Programs of India PvPiSachinKumar2160
Brief Introduction to China FDA 2014Brief Introduction to China FDA 2014
Brief Introduction to China FDA 2014Asian Food Regulation Information Service
International Pharmacist InstituteInternational Pharmacist Institute
International Pharmacist Instituteitechcrop

Último

ROJoson PEP Talk: Epidermal Cysts in SkinROJoson PEP Talk: Epidermal Cysts in Skin
ROJoson PEP Talk: Epidermal Cysts in SkinReynaldo Joson
Early Childhood Focus Group PresentationEarly Childhood Focus Group Presentation
Early Childhood Focus Group PresentationChesapeakeVirginiaWe
Expert Insights on Optimizing Patient Outcomes With Novel EHL FVIII Strategie...Expert Insights on Optimizing Patient Outcomes With Novel EHL FVIII Strategie...
Expert Insights on Optimizing Patient Outcomes With Novel EHL FVIII Strategie...PVI, PeerView Institute for Medical Education
Chương 3. Tài liệu EU GMP.pdfChương 3. Tài liệu EU GMP.pdf
Chương 3. Tài liệu EU GMP.pdfCông ty cổ phần GMPc Việt Nam | Tư vấn GMP, HS GMP, CGMP ASEAN, EU GMP, WHO GMP
infographic-01.pdfinfographic-01.pdf
infographic-01.pdfRevitalizeOgranicSto
Movement Disorders- M_Saidi- 21_01_20.pptxMovement Disorders- M_Saidi- 21_01_20.pptx
Movement Disorders- M_Saidi- 21_01_20.pptxMagicStudio

Último(20)

CDSCO and ADR reporting in India